Given the rapid spread of the coronavirus disease 2019 (COVID-19) pandemic and its overwhelming effect on health care systems and the global economy, innovative therapeutic strategies are urgently needed. The proposed primary culprit of COVID-19 is the intense inflammatory response—an augmented immune response and cytokine storm—severely damaging the lung tissue and rendering some patients’ conditions severe enough to require assisted ventilation. Sex differences in the response to inflammation have been documented and can be attributed, at least in part, to sex steroid hormones. Moreover, age-associated decreases in sex steroid hormones, namely, estrogen and testosterone, may mediate proinflammatory increases in older adults that could increase their risk of COVID-19 adverse outcomes. Sex hormones can mitigate the inflammation response and might provide promising therapeutic potential for patients with COVID-19. In this article, we explore the possible anti-inflammatory effects of estrogen and testosterone and the anabolic effect of testosterone, with particular attention to the potential therapeutic role of hormone replacement therapy in older men and women with COVID-19.
Abbreviations and Acronyms
ACE2
angiotensin-converting enzyme type 2
Ang II
angiotensin II
AT1R
type 1 angiotensin receptor
COVID-19
coronavirus disease 2019
IL-1/6/8
interleukin-1/6/8
NF-κB
nuclear factor κB
SARS-CoV-2
severe acute respiratory syndrome coronavirus 2
TNF-α
tumor necrosis factor α
Cited by (0)
Potential Competing Interests: Dr Baillargeon has received payment for consulting from AbbVie, Auxilium, Endo Pharmaceuticals, and GlaxoSmithKline. Dr Volpi has received a grant from the National Institutes of Health (P30 AG024832) and other support from the University of Texas Medical Branch. The other authors report no competing interests.
